These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8520810)

  • 1. Combined drug therapy with diltiazem, dextran, and hydrocortisone (DDH therapy) for late cerebral vasospasm after aneurysmal subarachnoid hemorrhage: assessment of efficacy and safety in an open clinical study.
    Kawano T; Kazekawa K; Nakashima S; Kohno H; Tanaka N; Honma T; Kaneko Y; Satoh K
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):513-7. PubMed ID: 8520810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage.
    Kinouchi H; Ogasawara K; Shimizu H; Mizoi K; Yoshimoto T
    Neurol Med Chir (Tokyo); 2004 Nov; 44(11):569-75; discussion 576-7. PubMed ID: 15686175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans.
    Thomas JE; Rosenwasser RH
    Neurosurgery; 1999 Jan; 44(1):48-57; discussion 57-8. PubMed ID: 9894963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage.
    Tokiyoshi K; Ohnishi T; Nii Y
    Surg Neurol; 1991 Aug; 36(2):112-8. PubMed ID: 1891755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage.
    Lasner TM; Weil RJ; Riina HA; King JT; Zager EL; Raps EC; Flamm ES
    J Neurosurg; 1997 Sep; 87(3):381-4. PubMed ID: 9285602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of calcium antagonist (diltiazem) on symptomatic cerebral vasospasm--with special reference to CT classification].
    Takagi T; Shimazu N; Fukuoka H; Nagai H; Ozawa M; Nagatomi H
    No Shinkei Geka; 1986 Nov; 14(12):1431-7. PubMed ID: 3808204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial.
    Shibuya M; Suzuki Y; Sugita K; Saito I; Sasaki T; Takakura K; Nagata I; Kikuchi H; Takemae T; Hidaka H
    J Neurosurg; 1992 Apr; 76(4):571-7. PubMed ID: 1545249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clot removal on cerebral vasospasm.
    Inagawa T; Yamamoto M; Kamiya K
    J Neurosurg; 1990 Feb; 72(2):224-30. PubMed ID: 2295920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients.
    Kodama N; Sasaki T; Kawakami M; Sato M; Asari J
    Surg Neurol; 2000 Feb; 53(2):110-7; discussion 117-8. PubMed ID: 10713187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
    Haley EC; Kassell NF; Torner JC
    J Neurosurg; 1993 Apr; 78(4):537-47. PubMed ID: 8450326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
    Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
    J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm.
    Kinugasa K; Kamata I; Hirotsune N; Tokunaga K; Sugiu K; Handa A; Nakashima H; Ohmoto T; Mandai S; Matsumoto Y
    J Neurosurg; 1995 Jul; 83(1):34-41. PubMed ID: 7782847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage.
    Kawamoto S; Tsutsumi K; Yoshikawa G; Shinozaki MH; Yako K; Nagata K; Ueki K
    J Neurosurg; 2004 Feb; 100(2):236-43. PubMed ID: 15086230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Mori K; Arai H; Nakajima K; Tajima A; Maeda M
    Stroke; 1995 Sep; 26(9):1620-6. PubMed ID: 7660409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of high dose nicardipine in patients with ruptured cerebral aneurysm].
    Kitano H; Matsuda M
    Nihon Geka Hokan; 1993 Nov; 62(6):287-93. PubMed ID: 8092922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of vasospasm in the treatment of ruptured intracranial aneurysms.
    Saito I; Ueda Y; Sano K
    J Neurosurg; 1977 Sep; 47(3):412-29. PubMed ID: 894345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage.
    Bejjani GK; Bank WO; Olan WJ; Sekhar LN
    Neurosurgery; 1998 May; 42(5):979-86; discussion 986-7. PubMed ID: 9588541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.
    Findlay JM; Weir BK; Kassell NF; Disney LB; Grace MG
    J Neurosurg; 1991 Aug; 75(2):181-8. PubMed ID: 1906533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
    J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.